RecruitingNCT06820515

ATHNdataset Registry

American Thrombosis and Hemostasis Network ATHNdataset Registry


Sponsor

American Thrombosis and Hemostasis Network

Enrollment

200,000 participants

Start Date

Oct 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.


Eligibility

Inclusion Criteria3

  • Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate.
  • Participants of any age.
  • Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent

Exclusion Criteria1

  • Any participant unable to provide consent or assent to participate in the ATHNdataset

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

American Thrombosis and Hemostasis Network

Hickory, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06820515


Related Trials